Pharmafile Logo
Pharmafocus logo
Advanced Search
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

October 9, 2020
Medical Communications coronavirus, news

The top ten news stories this week focus on clinical trial data, as Amgen and Novartis have revealed new five-year …

News
david_nicholson

Allergan R&D Chief named as Chairman of Exscientia’s Board of Directors

October 8, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Exscientia, appointment

Artificial intelligence-driven drug discovery firm Exscientia has named industry veteran Dr David Nicholson, current Executive Vice President and Chief R&D …

Appointment
nick_johnson_-_colour_2_1

Dr Nick Johnson appointed as Chief Strategy and Impact Officer of CGT Catapult

October 8, 2020
Business Services

Dr Nick Johnson has been appointed the Chief Strategy and Impact Officer of the Cell and Gene Therapy Catapult. Johnson …

Appointment
800px-eli_lilly_corporate_center_indianapolis_indiana_usa

Eli Lilly’s antibody COVID-19 therapy reduces virus levels and hospitalisations

October 8, 2020
Manufacturing and Production Eli Lilly, FDA

Eli Lilly is seeking Emergency Use Authorization from the FDA after releasing interim data based on early trial results.

News
800px-white_house_dc

34 reported coronavirus infections in White House-linked staff

October 8, 2020
Medical Communications COVID, Trump, US, white house

The coronavirus outbreak that has infected notable figures of the Trump administration has spread to 34 White House Staffers and …

News
nhs-westminster

COVID-19 has caused over three times more deaths than flu or pneumonia in England and Wales

October 8, 2020
Medical Communications, Research and Development COVID-19, UK, flu

Newly released data has revealed that COVID-19 has resulted in many more deaths than influenza or pneumonia in England and …

News
president_of_the_united_states_donald_j

Regeneron applies for FDA Emergency Use Authorization for COVID-19 antibody treatment given to Trump

October 8, 2020
Manufacturing and Production COVID, Trump, coronavirus

Regeneron has announced that it has applied for an Emergency Use Authorization from the FDA for its experimental antibody therapy …

News
shutterstock_2

Gilead to meet rising remdesivir demand in Europe with new supply deal

October 8, 2020
Manufacturing and Production COVID-19, Europe, Gilead

The European Commission (EC) has signed a new joint procurement agreement (JPA) with pharma firm Gilead to improve access to …

News
woman-smartphone-girl-technology

GSK tells UK staff to turn off NHS COVID-19 tracking app while at work

October 7, 2020
Research and Development COVID, GSK, covid app

GlaxoSmithKline has told its employees to turn off the new NHS coronavirus tracking app at work as it could be …

News
26190151124_fa4ae08b82_b

Johnson & Johnson to spend over $100m to settle 1,000 talc powder lawsuits

October 7, 2020
Research and Development

Johnson & Johnson have agreed to pay over $100 million to settle more than 1,000 lawsuits that blame the company’s …

News
glenmark

FDA greenlights Glenmark’s generic version of Biogen’s Tecfidera in relapsing multiple sclerosis

October 7, 2020
Research and Development, Sales and Marketing Biogen, Glenmark, generic, multiple sclerosis

Glenmark Pharma will be celebrating after it secured FDA approval in the US to market dimethyl fumarate, a generic version …

News
injection-2248377_960_720

EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine

October 7, 2020
Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine

European Medicines Agency has launched a “rolling review” of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

October 7, 2020
Research and Development COVID, COVID-19, corornavirus

The coronavirus news this week focuses on treatments, with Enlivex Therapeutics releasing positive data for its therapy Allocetra as a …

News
bel-n-garijo-large

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO

October 6, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …

Appointment
headache

Aimovig reduces frequency of episodic migraines, five-year data reveals

October 6, 2020
Manufacturing and Production, Research and Development Aimovig

Amgen and Novartis have revealed new five-year Phase 2 data during the Migraine Trust Virtual Symposium for their calcitonin gene-related …

News
800px-nhs_nnuh_entrance

NHS warns that UK could face drugs shortages after Brexit stockpile has been used to fight COVID-19

October 6, 2020
Manufacturing and Production

The NHS has warned that hospitals could face shortages of drugs during the second wave of coronavirus due to the …

News
fda2outsideweb

Opdivo/Yervoy combo secures FDA approval for malignant pleural mesothelioma

October 6, 2020
Manufacturing and Production, Research and Development Bristol-Myers Squibb, Yervoy, bristol myers squibb, opdivo

Bristol Myers Squibb’s therapy regimen of Opdivo (nivolumab) in combination with Yervoy (ipilimumab) has secured FDA approval for the first-line …

News
fda_21_4_1

White House halts release of new FDA standards for the Emergency Use Authorization of COVID-19 vaccine

October 6, 2020
Manufacturing and Production FDA, Trump, Vaccine, coronavirus vaccines

The Trump White House is blocking new federal guidance for the emergency release of coronavirus vaccines that would essentially ensure …

News
4353113087_4d19c3a402_b_1

Bristol Myers Squibb agrees $13 billion deal to acquire MyoKardia

October 6, 2020
Manufacturing and Production BSM, FDA, MyoKardia

Bristol Myers Squibb (BMS) is to purchase MyoKardia for $13 billion to boost its heart disease treatments portfolio. The deal …

News
shutterstock_138095450

Alivio Therapeutics receives $3.3m from US Department of Defense to support development of IBD drug candidate

October 5, 2020
Research and Development, Sales and Marketing Alivio, US, ibd, pharma

The US Department of Defense (DoD) has committed a Technology/Therapeutic Development Award to the value of $3.3 million to biotech …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026